Noise-induced Hearing Loss Clinical Trial
Official title:
A Phase 2A Randomized, Placebo Controlled, Double Blind Study of the Protective Effects of EPI-743 (VincerinoneTM) on Noise-Induced Hearing Loss
If effective, administration of EPI-743 should have protective effects against temporary noise-induced hearing loss.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02903355 -
Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)
|
Phase 3 | |
Terminated |
NCT01345474 -
Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)
|
Phase 3 | |
Withdrawn |
NCT02049073 -
Prevention of Noise-induced Hearing Loss
|
Phase 1/Phase 2 | |
Completed |
NCT02259595 -
Study to Determine the Safety, Tolerability, and Pharmacokinetic Profile of HPN-07 and HPN-07 Plus NAC
|
Phase 1 | |
Completed |
NCT00808470 -
Micronutrients to Prevent Noise-induced Hearing Loss
|
Phase 2 | |
Recruiting |
NCT01727492 -
Prevention of Noise-induced Damage by Use of Antioxidants
|
N/A | |
Completed |
NCT01454895 -
Test of a Web-based Intervention to Promote Hearing Protector Use
|
N/A | |
Completed |
NCT02472821 -
Test of Hearing Health Education Programs for Farm and Rural Youth
|
N/A |